DIN 02438399 — ACT BORTEZOMIB 3.5 MG
ACT BORTEZOMIB is a powder for solution of Bortezomib marketed by TEVA CANADA LIMITED. The full Bortezomib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02438399
- Brand name
- ACT BORTEZOMIB
- Active ingredient
- Bortezomib
- Strength
- 3.5 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Proteasome inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bortezomib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02456176 | BORTEZOMIB | 3.5 MG | POWDER FOR SOLUTION | APOTEX INC | MARKETED |
| 02467003 | BORTEZOMIB FOR INJECTION | 2.5 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02423405 | BORTEZOMIB FOR INJECTION | 3.5 MG | POWDER FOR SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02452456 | BORTEZOMIB FOR INJECTION | 3.5 MG | POWDER FOR SOLUTION | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02485257 | BORTEZOMIB FOR INJECTION | 3.5 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED |
| 02493306 | BORTEZOMIB FOR INJECTION | 3.5 MG | POWDER FOR SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02550075 | BORTEZOMIB INJECTION | 2.5 MG | SOLUTION | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02466708 | PMS-BORTEZOMIB | 3.5 MG | POWDER FOR SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02511932 | TARO-BORTEZOMIB | 2.5 MG | POWDER FOR SOLUTION | TARO PHARMACEUTICALS INC | MARKETED |
| 02499061 | TARO-BORTEZOMIB | 3.5 MG | POWDER FOR SOLUTION | TARO PHARMACEUTICALS INC | MARKETED |
| 02262452 | VELCADE | 3.5 MG | POWDER FOR SOLUTION | JANSSEN INC | MARKETED |